Developing methods for benefit measurement in health-related economic analyses and their use in selecting public health promotional programs. The program involves the creation, validation and use of a suite of instruments for evaluating outcomes of health promotional programs, including adult and childhood obesity, depression and smoking - areas that are universally recognised as being of importance for the Australian community. The program will provide multiple scoring algorithms for each of th ....Developing methods for benefit measurement in health-related economic analyses and their use in selecting public health promotional programs. The program involves the creation, validation and use of a suite of instruments for evaluating outcomes of health promotional programs, including adult and childhood obesity, depression and smoking - areas that are universally recognised as being of importance for the Australian community. The program will provide multiple scoring algorithms for each of the instruments in order to test the sensitivity of results to assumptions made about social values, and will produce Australian estimates of the person trade-off weights used in the Australian and Victorian Burden of Disease studies (which presently use Dutch PTO weights). Read moreRead less
Motor vehicle injuries: economic evaluation of a new treatment modality. The management of injured persons following motor vehicle accidents is a serious health issue in Australia, with over 60,000 minor injuries and 20,000 major injuries occurring annually. This project will provide a cost-effectiveness analysis of a new multidisciplinary approach to managing minor injuries by utilising data from the Accident Care Evaluation (ACE) trial of a new clinic being tested for this purpose.
Coverage with Evidence Development: Application to pharmaceutical reimbursement decisions. Some new medicines produce only a small improvement in health but have considerable costs. When these medicines are trialled on only small numbers of people, uncertainty results about the value of the medicine, which can create problems for decision makers. Funding medicines where there is uncertainty may lead to harm when medicines are later found to be unsafe, or waste millions of dollars when they are ....Coverage with Evidence Development: Application to pharmaceutical reimbursement decisions. Some new medicines produce only a small improvement in health but have considerable costs. When these medicines are trialled on only small numbers of people, uncertainty results about the value of the medicine, which can create problems for decision makers. Funding medicines where there is uncertainty may lead to harm when medicines are later found to be unsafe, or waste millions of dollars when they are overpriced relative to effectiveness. Not funding medicines may disadvantage patients in whom the medicines are effective. Methods to enable access to medicines while reducing uncertainty will offer significant benefit to patients, clinicians and taxpayers. Read moreRead less
The identification and measurement of equity and other health sector objectives. The project will investigate public expectations and values about the health system. The results will: (i) challenge the recent WHO evaluation of health systems in which 75 percent of the total score came from objectives other than population health; (ii) provide policy makers with numerical scores to indicate the relative importance of different broad objectives (such as access and the distribution of health servic ....The identification and measurement of equity and other health sector objectives. The project will investigate public expectations and values about the health system. The results will: (i) challenge the recent WHO evaluation of health systems in which 75 percent of the total score came from objectives other than population health; (ii) provide policy makers with numerical scores to indicate the relative importance of different broad objectives (such as access and the distribution of health services and the question of access to services); (iii) provide health service researchers with numerical scores to indicate where there are higher priority services or recipients: for example, the young or those with long term disabilities.Read moreRead less
COst-effectiveness analyses of improved adherence to Management PLans among AustralIANS (COMPLIANS). Chronic diseases are the leading cause of disability in the community and over $34billion is spent each year on health services in Australia treating these diseases. It is hoped that the project will lead to identification of opportunities for cost-effective prevention and treatment of lung and other chronic diseases and that this will lead to more cost-effective deployment of healthcare resourc ....COst-effectiveness analyses of improved adherence to Management PLans among AustralIANS (COMPLIANS). Chronic diseases are the leading cause of disability in the community and over $34billion is spent each year on health services in Australia treating these diseases. It is hoped that the project will lead to identification of opportunities for cost-effective prevention and treatment of lung and other chronic diseases and that this will lead to more cost-effective deployment of healthcare resources. Improvements in the management and treatment of these diseases will result in an improvement in the quality of life of Australian patients, and their active and productive participation in society for as long as possible.Read moreRead less
Bargaining and the price of new pharmaceuticals in Australia: An empirical analysis. The proposed research will consider whether there is a trade-off between price and access and will identify features of the regulatory framework that contribute to delays in securing access to drugs for diseases with no alternative therapy. It will provide decision makers with the necessary information to negotiate the lowest achievable price for drugs, freeing up resources for use elsewhere in the health sector ....Bargaining and the price of new pharmaceuticals in Australia: An empirical analysis. The proposed research will consider whether there is a trade-off between price and access and will identify features of the regulatory framework that contribute to delays in securing access to drugs for diseases with no alternative therapy. It will provide decision makers with the necessary information to negotiate the lowest achievable price for drugs, freeing up resources for use elsewhere in the health sector or slowing the growth in healthcare expenditure.Read moreRead less
Drug Companies, their Patenting Strategies and High-Cost Pharmaceuticals: An Empirical Investigation. Pharmaceuticals are a vital part of clinical services that maintain and improve Australia's health; they are also costly, absorbing a substantial proportion of the national health expenditures. By conferring market protections, the patent system helps the manufacturers of pharmaceuticals to recoup the high costs of research associated with developing new products. Abuses of the patent system by ....Drug Companies, their Patenting Strategies and High-Cost Pharmaceuticals: An Empirical Investigation. Pharmaceuticals are a vital part of clinical services that maintain and improve Australia's health; they are also costly, absorbing a substantial proportion of the national health expenditures. By conferring market protections, the patent system helps the manufacturers of pharmaceuticals to recoup the high costs of research associated with developing new products. Abuses of the patent system by pharmaceutical manufacturers have the potential to stifle competition and inappropriately raise the costs of pharmaceuticals to society. This innovative, cross-disciplinary, research will investigate the existence of abusive patents and, if necessary, propose reforms that will prevent further abuse and reduce the size of the health budget. Read moreRead less
Long term economic impacts of disease on older workers to 2030: Costs to government and individuals and opportunities for intervention. This project will fill substantial gaps in Australian evidence about the health conditions of the future that will keep older workers out of the labour market and diminish their own immediate and long-term livings standards, thereby reducing funds available to government. We will address one of the most significant issues resulting from the fundamental changes t ....Long term economic impacts of disease on older workers to 2030: Costs to government and individuals and opportunities for intervention. This project will fill substantial gaps in Australian evidence about the health conditions of the future that will keep older workers out of the labour market and diminish their own immediate and long-term livings standards, thereby reducing funds available to government. We will address one of the most significant issues resulting from the fundamental changes to the demography of the Australian labour market and one that is regularly raised by the government following the release of the 2002 and 2007 Intergenerational Reports. This project will also examine the interventions that would improve the health of older workers and increase labour force participation over the long term.Read moreRead less
Economic Modelling of the Nurses' Labour Market in Australia. Nurses play an important role in the health system and help to ensure individuals lead healthier, happier and more productive lives. Devising cost-effective policies to ensure an adequate supply of motivated and productive nurses is crucial in achieving efficiency and equity in the health care system. The results will be used by government to help set optimal pay and conditions for nurses, and to ensure that these are competitive with ....Economic Modelling of the Nurses' Labour Market in Australia. Nurses play an important role in the health system and help to ensure individuals lead healthier, happier and more productive lives. Devising cost-effective policies to ensure an adequate supply of motivated and productive nurses is crucial in achieving efficiency and equity in the health care system. The results will be used by government to help set optimal pay and conditions for nurses, and to ensure that these are competitive with other nurse employers. This will provide a firm evidence-base to reduce nurse shortages and therefore increase the quality of patient care in Australia.Read moreRead less
Financing aged care in Australia: Mitigating fiscal gaps and maintaining intergenerational equity. Aged care has been identified as a significant contributor to the growing fiscal problems predicted for Australian government finances during the next 10 to 20 years. This project will develop the cutting-edge modelling tools needed to allow Australia to make informed decisions about possible reforms in aged care financing. It will create significant national benefits by allowing detailed assessmen ....Financing aged care in Australia: Mitigating fiscal gaps and maintaining intergenerational equity. Aged care has been identified as a significant contributor to the growing fiscal problems predicted for Australian government finances during the next 10 to 20 years. This project will develop the cutting-edge modelling tools needed to allow Australia to make informed decisions about possible reforms in aged care financing. It will create significant national benefits by allowing detailed assessment of the distributional impact of a wide range of possible reforms, including how the outcomes of any policy change will affect disadvantaged sections of our society, whether different generations will be fairly treated, and the impact by gender.Read moreRead less